Cart summary

You have no items in your shopping cart.

ANKRD30A/NY-BR-1 Antibody

Catalog Number: orb1539288

Select Product Size
SizePriceQuantity
50 μl$ 660.00
50 μl Enquire
DispatchUsually dispatched within 2-3 weeks
Product Properties
Catalog Numberorb1539288
CategoryAntibodies
DescriptionANKRD30A/NY-BR-1 Antibody
TargetANKRD30A / NY-BR-1
ClonalityPolyclonal
Species/HostRabbit
IsotypeIgG
ConjugationUnconjugated
ReactivityHuman
Concentration1 mg/ml
Buffer/PreservativesPBS (without Mg2+, Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol. PBS (without Mg2+, Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide, 50% Glycerol
PurificationImmunoaffinity purified
ImmunogenSynthetic peptide from human AN30A. (AA Range: 1041-1090)
Tested applicationsELISA, IHC, IHC-P, WB
Dilution rangeIHC, IHC-P (1:50), Peptide-ELISA (1:1000), WB (1:500 - 1:1000)
Application notesFurther information: Western Blot: Predicted MW 152 kDa
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Alternative namesANKRD30A, NY-BR-1, RP11-20F24.1, Ankyrin repeat do
Read more...
NoteFor research use only
Images
ANKRD30A/NY-BR-1 Antibody

Human, Testis: Formalin-Fixed Paraffin-Embedded (FFPE)

ANKRD30A/NY-BR-1 Antibody

Western blot analysis of lysates from 293 and COLO cells, using AN30A Antibody. The lane on the right is blocked with the synthesized peptide.

Similar Products
  • ANKRD30A/NY-BR-1 Antibody [orb1536149]

    IHC,  IHC-P,  WB

    Human

    Rabbit

    Polyclonal

    Unconjugated

    50 μl
  • Human ANKRD30A/NY-BR-1 Antibody (SAA1895) [orb2958712]

    ELISA

    Human

    Mouse

    Monoclonal

    Unconjugated

    1 mg, 100 μg, 50 μg
Reviews

ANKRD30A/NY-BR-1 Antibody (orb1539288)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet